Neogenomics Inc (NEO)

$7.00 +0.05 (0.72%)
Market Cap 900.87M
Revenue (ttm) 660.57M
Net Income (ttm) -78.73M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -11.92%
Debt to Equity Ratio 0.23
Volume 2,345,900
Avg Vol 2,410,250
Day's Range N/A - N/A
Shares Out 128.70M
Stochastic %K 13%
Beta 1.65
Analysts Strong Sell
Price Target $14.46

Company Profile

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through two segments: Clinical Services and Advanced Diagnostics. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-s...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 239 768 0600
Fax: 239 690 4237
Address:
9490 NeoGenomics Way, Fort Myers, United States
DriveForShow
DriveForShow Jun. 20 at 3:55 PM
$NEO
0 · Reply
brijith86
brijith86 Jun. 17 at 10:59 PM
$NEO 4.35 million shares added to dree float
0 · Reply
Dillydilly26
Dillydilly26 Jun. 16 at 11:32 PM
$NEO wtf did I buy calls in. Bought the wrong Neo 😂 fml 🤦
0 · Reply
LetsWinSD
LetsWinSD Jun. 16 at 2:33 PM
$NEO
0 · Reply
SmartTradeusa
SmartTradeusa Jun. 16 at 10:14 AM
$TMDE Watchlist $NEHC $RSLS $TMDE $NEO
0 · Reply
brijith86
brijith86 Jun. 13 at 6:25 PM
$NEO waiting
0 · Reply
LetsWinSD
LetsWinSD Jun. 9 at 1:14 PM
$NEO boring.
0 · Reply
brijith86
brijith86 Jun. 2 at 9:53 PM
$NEO bloodbath tomorrow
2 · Reply
brijith86
brijith86 Jun. 2 at 9:36 PM
$NEO boom
0 · Reply
brijith86
brijith86 Jun. 2 at 8:14 PM
$NEO
0 · Reply
Latest News on NEO
NeoGenomics Debuts PanTracer Family of Genomic Profiling Tests at ASCO 2025

May 28, 2025, 7:10 AM EDT - 25 days ago

NeoGenomics Debuts PanTracer Family of Genomic Profiling Tests at ASCO 2025

NeoGenomics Launches c-MET CDx Assay to Guide Treatment Decisions for Advanced Non-Small Cell Lung Cancer

May 22, 2025, 7:10 AM EDT - 4 weeks ago

NeoGenomics Launches c-MET CDx Assay to Guide Treatment Decisions for Advanced Non-Small Cell Lung Cancer

NeoGenomics to Participate in Upcoming June Investor Conferences

May 20, 2025, 7:05 AM EDT - 4 weeks ago

NeoGenomics to Participate in Upcoming June Investor Conferences

NeoGenomics Pays Off 1.25% Convertible Senior Notes

May 1, 2025, 7:05 AM EDT - 7 weeks ago

NeoGenomics Pays Off 1.25% Convertible Senior Notes

NeoGenomics Q1 Earnings: The Stock Price Drop Is A Gift (Rating Upgrade)

Apr 30, 2025, 9:00 AM EDT - 7 weeks ago

NeoGenomics Q1 Earnings: The Stock Price Drop Is A Gift (Rating Upgrade)

NeoGenomics, Inc (NEO) Q1 2025 Earnings Call Transcript

Apr 29, 2025, 12:18 PM EDT - 7 weeks ago

NeoGenomics, Inc (NEO) Q1 2025 Earnings Call Transcript

NeoGenomics and Ultima Genomics collaborate to expand clinical test offerings in Oncology using the UG 100 sequencing platform

Apr 29, 2025, 8:00 AM EDT - 7 weeks ago

NeoGenomics and Ultima Genomics collaborate to expand clinical test offerings in Oncology using the UG 100 sequencing platform

NeoGenomics Reports First Quarter 2025 Results

Apr 29, 2025, 7:30 AM EDT - 7 weeks ago

NeoGenomics Reports First Quarter 2025 Results

NeoGenomics to Showcase PanTracer LBx Validation Study at AACR Annual Meeting

Apr 22, 2025, 7:05 AM EDT - 2 months ago

NeoGenomics to Showcase PanTracer LBx Validation Study at AACR Annual Meeting

NeoGenomics to Report First Quarter 2025 Financial Results on April 29, 2025

Apr 8, 2025, 7:05 AM EDT - 2 months ago

NeoGenomics to Report First Quarter 2025 Financial Results on April 29, 2025

NeoGenomics Completes Acquisition of Pathline

Apr 7, 2025, 7:05 AM EDT - 2 months ago

NeoGenomics Completes Acquisition of Pathline

Tony Zook Assumes Role as Chief Executive Officer of NeoGenomics

Apr 1, 2025, 7:05 AM EDT - 2 months ago

Tony Zook Assumes Role as Chief Executive Officer of NeoGenomics

NeoGenomics Expands Oncology Testing Reach in the Northeast with Acquisition of Pathline

Mar 10, 2025, 7:00 AM EDT - 3 months ago

NeoGenomics Expands Oncology Testing Reach in the Northeast with Acquisition of Pathline

NeoGenomics: Decent Fundamentals, But Still Overvalued

Feb 28, 2025, 3:39 AM EST - 4 months ago

NeoGenomics: Decent Fundamentals, But Still Overvalued

NeoGenomics to Participate in Upcoming Investor Conferences

Feb 24, 2025, 7:05 AM EST - 4 months ago

NeoGenomics to Participate in Upcoming Investor Conferences

NeoGenomics, Inc (NEO) Q4 2024 Earnings Call Transcript

Feb 18, 2025, 12:22 PM EST - 4 months ago

NeoGenomics, Inc (NEO) Q4 2024 Earnings Call Transcript

NeoGenomics Reports Fourth Quarter and Full Year 2024 Results

Feb 18, 2025, 7:05 AM EST - 4 months ago

NeoGenomics Reports Fourth Quarter and Full Year 2024 Results

NeoGenomics to Report Fourth Quarter and Full Year 2024 Financial Results on February 18, 2025

Jan 29, 2025, 8:05 AM EST - 5 months ago

NeoGenomics to Report Fourth Quarter and Full Year 2024 Financial Results on February 18, 2025

NeoGenomics Provides 2025 Financial Guidance and Updates Long-Range Financial Plan

Jan 15, 2025, 7:05 AM EST - 5 months ago

NeoGenomics Provides 2025 Financial Guidance and Updates Long-Range Financial Plan

NeoGenomics Announces Chief Executive Officer Succession

Jan 10, 2025, 7:05 AM EST - 5 months ago

NeoGenomics Announces Chief Executive Officer Succession

NeoGenomics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Jan 6, 2025, 7:55 AM EST - 5 months ago

NeoGenomics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

NeoGenomics' Newly Published Study Underscores Potential of ctDNA as a Predictive Tool for Monitoring Patients with High-Risk Melanoma

Dec 11, 2024, 8:05 AM EST - 6 months ago

NeoGenomics' Newly Published Study Underscores Potential of ctDNA as a Predictive Tool for Monitoring Patients with High-Risk Melanoma

NeoGenomics to Present Key Research on Hematologic Malignancies at the 2024 American Society of Hematology Annual Meeting

Dec 9, 2024, 8:10 AM EST - 6 months ago

NeoGenomics to Present Key Research on Hematologic Malignancies at the 2024 American Society of Hematology Annual Meeting

ConcertAI and NeoGenomics Announce New AI Software-as-a-Service Solution for Hematology Clinical Research

Dec 5, 2024, 7:00 AM EST - 7 months ago

ConcertAI and NeoGenomics Announce New AI Software-as-a-Service Solution for Hematology Clinical Research

NeoGenomics to Present New Data at AMP 2024, Highlighting the Impact of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment

Nov 19, 2024, 8:15 AM EST - 7 months ago

NeoGenomics to Present New Data at AMP 2024, Highlighting the Impact of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment

Felicia Williams Joins NeoGenomics Board of Directors

Nov 14, 2024, 8:10 AM EST - 7 months ago

Felicia Williams Joins NeoGenomics Board of Directors

NeoGenomics to Participate in the Piper Sandler 36th Annual Healthcare Conference

Nov 8, 2024, 7:00 AM EST - 8 months ago

NeoGenomics to Participate in the Piper Sandler 36th Annual Healthcare Conference

NeoGenomics, Inc. (NEO) Q3 2024 Earnings Call Transcript

Nov 5, 2024, 1:27 PM EST - 8 months ago

NeoGenomics, Inc. (NEO) Q3 2024 Earnings Call Transcript

NeoGenomics Reports Third Quarter 2024 Results

Nov 5, 2024, 7:00 AM EST - 8 months ago

NeoGenomics Reports Third Quarter 2024 Results

NeoGenomics Receives New York State Approval for Neo Comprehensive™ Solid Tumor Test

Oct 22, 2024, 8:10 AM EDT - 8 months ago

NeoGenomics Receives New York State Approval for Neo Comprehensive™ Solid Tumor Test

NeoGenomics to Report Third Quarter 2024 Financial Results on Nov. 5, 2024

Oct 15, 2024, 7:30 AM EDT - 8 months ago

NeoGenomics to Report Third Quarter 2024 Financial Results on Nov. 5, 2024

NeoGenomics Launches AML Express for Rapid Genetic Profiling of Acute Myeloid Leukemia

Oct 8, 2024, 8:10 AM EDT - 9 months ago

NeoGenomics Launches AML Express for Rapid Genetic Profiling of Acute Myeloid Leukemia

NeoGenomics Inc (NEO) Shares Up 3.95% on Oct 2

Oct 2, 2024, 12:10 PM EDT - 9 months ago

NeoGenomics Inc (NEO) Shares Up 3.95% on Oct 2

NeoGenomics Announces New RaDaR Technology and Resolution of RaDaR 1.0 Litigation

Sep 23, 2024, 6:47 PM EDT - 9 months ago

NeoGenomics Announces New RaDaR Technology and Resolution of RaDaR 1.0 Litigation

NeoGenomics to Present New Data at ESMO 2024, Highlighting the Value of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment

Sep 11, 2024, 8:05 AM EDT - 10 months ago

NeoGenomics to Present New Data at ESMO 2024, Highlighting the Value of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment

NeoGenomics to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

Aug 29, 2024, 8:05 AM EDT - 10 months ago

NeoGenomics to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

NeoGenomics, Inc. (NEO) Q2 2024 Earnings Call Transcript

Jul 29, 2024, 8:14 PM EDT - 11 months ago

NeoGenomics, Inc. (NEO) Q2 2024 Earnings Call Transcript

NeoGenomics Reports Second Quarter 2024 Results

Jul 29, 2024, 4:05 PM EDT - 11 months ago

NeoGenomics Reports Second Quarter 2024 Results

NeoGenomics to Report Second Quarter 2024 Financial Results on July 29, 2024

Jul 9, 2024, 7:00 AM EDT - 1 year ago

NeoGenomics to Report Second Quarter 2024 Financial Results on July 29, 2024

Fort Myers' Mayor to Proclaim June as NeoGenomics' Commitment to Cancer Month

Jun 13, 2024, 8:00 AM EDT - 1 year ago

Fort Myers' Mayor to Proclaim June as NeoGenomics' Commitment to Cancer Month

Press release Biocartis NV: Biocartis Welcomes Gina Wallar, PhD as Chief Business Officer and Judith Vacchino, PhD as VP Global Marketing

Jun 10, 2024, 1:00 AM EDT - 1 year ago

Press release Biocartis NV: Biocartis Welcomes Gina Wallar, PhD as Chief Business Officer and Judith Vacchino, PhD as VP Global Marketing

FLGT

NeoGenomics to Introduce Comprehensive Lung Solution & Feature Hematopathology Services at ASCO, Offering Actionable Insights to Support Treatment Management

May 28, 2024, 8:05 AM EDT - 1 year ago

NeoGenomics to Introduce Comprehensive Lung Solution & Feature Hematopathology Services at ASCO, Offering Actionable Insights to Support Treatment Management

NeoGenomics, Inc. (NEO) Q1 2024 Earnings Call Transcript

Apr 30, 2024, 2:11 PM EDT - 1 year ago

NeoGenomics, Inc. (NEO) Q1 2024 Earnings Call Transcript

NeoGenomics Reports First Quarter 2024 Results

Apr 30, 2024, 7:30 AM EDT - 1 year ago

NeoGenomics Reports First Quarter 2024 Results

NeoGenomics Announces Senior Leadership Promotions

Apr 18, 2024, 7:05 AM EDT - 1 year ago

NeoGenomics Announces Senior Leadership Promotions

NeoGenomics to Report First Quarter 2024 Financial Results on April 30, 2024

Apr 9, 2024, 7:00 AM EDT - 1 year ago

NeoGenomics to Report First Quarter 2024 Financial Results on April 30, 2024

NeoGenomics Showcases Commitment to Transforming Cancer Patient Care at AACR 2024 Annual Meeting

Mar 27, 2024, 8:30 AM EDT - 1 year ago

NeoGenomics Showcases Commitment to Transforming Cancer Patient Care at AACR 2024 Annual Meeting

NeoGenomics Releases Inaugural Environmental, Social, and Governance (ESG) Report

Mar 20, 2024, 7:00 AM EDT - 1 year ago

NeoGenomics Releases Inaugural Environmental, Social, and Governance (ESG) Report

DriveForShow
DriveForShow Jun. 20 at 3:55 PM
$NEO
0 · Reply
brijith86
brijith86 Jun. 17 at 10:59 PM
$NEO 4.35 million shares added to dree float
0 · Reply
Dillydilly26
Dillydilly26 Jun. 16 at 11:32 PM
$NEO wtf did I buy calls in. Bought the wrong Neo 😂 fml 🤦
0 · Reply
LetsWinSD
LetsWinSD Jun. 16 at 2:33 PM
$NEO
0 · Reply
SmartTradeusa
SmartTradeusa Jun. 16 at 10:14 AM
$TMDE Watchlist $NEHC $RSLS $TMDE $NEO
0 · Reply
brijith86
brijith86 Jun. 13 at 6:25 PM
$NEO waiting
0 · Reply
LetsWinSD
LetsWinSD Jun. 9 at 1:14 PM
$NEO boring.
0 · Reply
brijith86
brijith86 Jun. 2 at 9:53 PM
$NEO bloodbath tomorrow
2 · Reply
brijith86
brijith86 Jun. 2 at 9:36 PM
$NEO boom
0 · Reply
brijith86
brijith86 Jun. 2 at 8:14 PM
$NEO
0 · Reply
brijith86
brijith86 Jun. 2 at 8:08 PM
$NEO 4.50 to 5 is good entry
0 · Reply
brijith86
brijith86 May. 30 at 1:35 PM
$NEO wait till 5 its going to good entry untill then dont buy a single one .
0 · Reply
brijith86
brijith86 May. 30 at 12:52 PM
$NEO 200 million dollar shares to be diluted soon
0 · Reply
premarketmaker
premarketmaker May. 29 at 8:03 PM
$NEO this is very hot - $4.83 has remained the target and will be quite the squeeze loaded with shorts
1 · Reply
LetsWinSD
LetsWinSD May. 29 at 2:58 PM
$NEO shut up. No offering coming. Neo is doing well.
0 · Reply
brijith86
brijith86 May. 28 at 7:47 PM
$NEO there is an offering coming soon
5 · Reply
LetsWinSD
LetsWinSD May. 28 at 4:17 PM
$NEO https://finance.yahoo.com/news/neogenomics-debuts-pantracer-family-genomic-111000651.html
0 · Reply
BioTuesdays
BioTuesdays May. 28 at 2:12 PM
NeoGenomics has announced that it will debut its PanTracer Family genomic profiling tests for advanced solid tumors at the 2025 American Society of Clinical Oncology (ASCO) in Chicago May 30—June 3, 2025 $NEO https://biotuesdays.com/2025/05/28/neogenomics-introduces-pantracer-genomic-profiling-tests-at-asco-2025/
0 · Reply
rusty8350
rusty8350 May. 27 at 8:03 PM
$NEO Come on NEO! You’re better than this 🤣
0 · Reply
LetsWinSD
LetsWinSD May. 27 at 5:20 PM
$NEO all other tickers are pumping while this POS is struggling.
0 · Reply
LetsWinSD
LetsWinSD May. 27 at 12:57 PM
$NEO https://finance.yahoo.com/news/neogenomics-introduces-c-met-companion-140937379.html
0 · Reply
rusty8350
rusty8350 May. 23 at 1:50 PM
$NEO Go green you turd 🤣
1 · Reply